GFM
BMY icon

GF Fund Management’s Bristol-Myers Squibb BMY Stock Holding History

GF Fund Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.37M Hold
55,513
– – 0.06% 144
2025
Q4 		$2.99M Sell
55,513
-1,047
-2% -$50.4K 0.05% 157
2025
Q3 		$2.55M Buy
56,560
+7,181
+15% +$335K 0.05% 166
2025
Q2 		$2.29M Sell
49,379
-369
-0.7% -$18.1K 0.05% 183
2025
Q1 		$3.03M Hold
49,748
– – 0.07% 160
2024
Q4 		$2.81M Buy
+49,748
New +$2.78M 0.06% 162

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GF Fund Management's BMY Position: Q1 2026 in Review

GF Fund Management held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 55,513 shares worth $3.37M. The position accounts for 0.06% of the portfolio, ranked #144.

GF Fund Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • GF Fund Management held 55,513 shares of Bristol-Myers Squibb worth $3.37M as of Q1 2026.
  • GF Fund Management left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.06% of GF Fund Management's portfolio in Q1 2026, its #144 holding.
  • GF Fund Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.